Three different therapies to target PCSK9

Volume: 18, Issue: 8, Pages: 541 - 541
Published: Jun 4, 2021
Abstract
PCSK9 inhibitors are a class of cholesterol-lowering drugs that regulate LDL-receptor degradation. Three new studies show successful reduction of PCSK9 levels by different approaches that all resulted in the lowering of LDL-cholesterol...
Paper Details
Title
Three different therapies to target PCSK9
DOI
Published Date
Jun 4, 2021
Journal
Volume
18
Issue
8
Pages
541 - 541
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.